The Association of Long-Functioning Hemodialysis Vascular Access with Prevalence of Left Ventricular Hypertrophy in Kidney Transplant Recipients

Table 3

The results of forward models of multivariate logistic regression analyses for left ventricular hypertrophy occurrence, measured based on both indices: LVMI/BSA and LVMI/height^2.7.

Independent variable	LVH based on LVM indexed for BSA		LVH based on LVM indexed for height^2.7
	OR	𝑃	OR	𝑃
Age (per year)	1.04 (1.01–1.07)	0.009	1.05 (1.01–1.09)	0.02
Duration of pretransplant dialysis therapy (per year)	1.16 (0.98–1.39)	0.09	1.30 (1.00–1.69)	0.04
eGFR (per mL/min/1.73 m^2)	0.98 (0.96–1.00)	0.03	—
BMI (per 1 kg/m^2)	—		1.22 (1.09–1.36)	<0.001
Patent vascular access	2.39 (1.19–4.76)	0.01	2.52 (0.99–6.47)	0.05

Data shown as means ± 95% CI. LVH: left ventricular hypertrophy, LVM: left ventricular mass, BSA: body surface area, eGFR: estimated glomerular filtration rate, and BMI: body mass index.